from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2065/cobH

LFCtreatmentdescriptionclass of inhibitor

-0.122

Amikacinug/mL Amikacintranslation

-0.671

Cap5-10ug/mL Capreomycintranslation

-0.806

Rox10-50 ug/mL Roxithromycintranslation

0.440

SM2-5 ug/mL Streptomycintranslation

0.795

Tet5-10 ug/mL Tetracyclinetranslation

1.221

Rif0.2-5ug/mL Rifampicintranscription

0.316

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.045

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.168

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.912

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.063

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.491

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.175

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.353

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.408

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.525

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.769

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.014

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.523

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.044

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.719

KCN5-20 ug/mL Potassium cyaniderespiration

0.002

NaN30.2-2 mM Sodium aziderespiration

-0.463

Nigericin50 uM Nigericinrespiration

0.156

TRC10-150 ug/mL Triclosanrespiration

-1.710

TRZ10-25 ug/mL Thioridazinerespiration

-0.501

Valinomycin0.5-10 uM Valinomycinrespiration

-1.412

ZnSO42 mM ZnSO4respiration

0.759

menadione6-10 ug/mL Menadionerespiration

-0.583

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.182

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.200

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.261

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.020

NRP_1Non-replicating persistence stage 1dosRassociated

0.383

Amp0.2mg/mL AmpicillincellWall

-0.480

Cephalexin20-100 ug/mL CephalexincellWall

-0.552

Cerulenin0.32-5 ug/mL CerulenincellWall

1.542

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.683

EMB10-20 ug/mL EthambutolcellWall

0.026

Eta12-40 ug/mL EthionamidecellWall

0.214

INH0.2-0.4 ug/mL IsoniazidcellWall

0.346

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.155

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.054

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.555

BZA0.12 mg/mL BenzamidearomaticAmides

0.303

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.623

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.325

H2O24 mM hydrogen peroxideDNAdamaging

0.040

Levo10 ug/mL LevofloxacinDNAdamaging

0.542

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.838

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.883

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.521

UVUV-irradiationDNAdamaging

1.570

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.058

Antimycin12.5-50 ug/mL Antimycin A?

-1.278

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.084

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.317

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.401

PA8240.2-2 ug/mL PA-824?

0.531

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.450

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.579

Verapamil50 uM Verapamil?

-0.311

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.722

methoxatin10-20 ug/mL Methoxatin?